dc.contributor.author | ABRAMOVICZ, D | |
dc.contributor.author | HOUSSIAU, FA | |
dc.contributor.author | VASCONCELOS, C | |
dc.contributor.author | D'CRUZ, D | |
dc.contributor.author | SEBASTIANI, GD | |
dc.contributor.author | GARRIDO, ED | |
dc.contributor.author | DANIELI, MG | |
dc.contributor.author | BLOCKMANS, D | |
dc.contributor.author | MATHIEU, A | |
dc.contributor.author | DIRESKENELI, H | |
dc.contributor.author | GALEAZZI, M | |
dc.contributor.author | LEVY, Y | |
dc.contributor.author | PETERA, P | |
dc.contributor.author | POPOVIC, R | |
dc.contributor.author | PETROVIC, R | |
dc.contributor.author | SINICO, RA | |
dc.contributor.author | CATTANEO, R | |
dc.contributor.author | FONT, J | |
dc.contributor.author | DEPRESSEUX, G | |
dc.contributor.author | COSYNS, JP | |
dc.contributor.author | CERVERA, R | |
dc.contributor.author | Gul, Ahmet | |
dc.date.accessioned | 2021-03-05T12:15:21Z | |
dc.date.available | 2021-03-05T12:15:21Z | |
dc.date.issued | 2002 | |
dc.identifier.citation | HOUSSIAU F., VASCONCELOS C., D'CRUZ D., SEBASTIANI G., GARRIDO E., DANIELI M., ABRAMOVICZ D., BLOCKMANS D., MATHIEU A., DIRESKENELI H., et al., "Immunosuppressive therapy in lupus nephritis - The Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide", ARTHRITIS AND RHEUMATISM, cilt.46, ss.2121-2131, 2002 | |
dc.identifier.issn | 0004-3591 | |
dc.identifier.other | av_ac42a9e1-cc30-45e0-b4cf-d3d512f8461b | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/114959 | |
dc.identifier.uri | https://doi.org/10.1002/art.10461 | |
dc.description.abstract | Objective. Glomerulonephritis is a severe manifestation of systemic lupus erythematosus (SLE) that is usually treated with an extended course of intravenous (IV) cyclophosphamide (CYC). Given the side effects of this regimen, we evaluated the efficacy and the toxicity of a course of low-dose IV CYC prescribed as a remission-inducing treatment, followed by azathioprine (AZA) as a remission-maintaining treatment. | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | İmmünoloji ve Romatoloji | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp | |
dc.subject | ROMATOLOJİ | |
dc.title | Immunosuppressive therapy in lupus nephritis - The Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide | |
dc.type | Makale | |
dc.relation.journal | ARTHRITIS AND RHEUMATISM | |
dc.contributor.department | , , | |
dc.identifier.volume | 46 | |
dc.identifier.issue | 8 | |
dc.identifier.startpage | 2121 | |
dc.identifier.endpage | 2131 | |
dc.contributor.firstauthorID | 50905 | |